Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity.

Palakurthi S, Kuraguchi M, Zacharek SJ, Zudaire E, Huang W, Bonal DM, Liu J, Dhaneshwar A, DePeaux K, Gowaski MR, Bailey D, Regan SN, Ivanova E, Ferrante C, English JM, Khosla A, Beck AH, Rytlewski JA, Sanders C, Laquerre S, Bittinger MA, Kirschmeier PT, Packman K, Janne PA, Moy C, Wong KK, Verona RI, Lorenzi MV.

Cancer Immunol Res. 2019 Sep;7(9):1457-1471. doi: 10.1158/2326-6066.CIR-18-0595. Epub 2019 Jul 22.

PMID:
31331945
2.

A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing.

Lizotte PH, Hong RL, Luster TA, Cavanaugh ME, Taus LJ, Wang S, Dhaneshwar A, Mayman N, Yang A, Kulkarni M, Badalucco L, Fitzpatrick E, Kao HF, Kuraguchi M, Bittinger M, Kirschmeier PT, Gray NS, Barbie DA, Jänne PA.

Cancer Immunol Res. 2018 Dec;6(12):1511-1523. doi: 10.1158/2326-6066.CIR-18-0193. Epub 2018 Sep 21.

3.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA.

Cancer Discov. 2018 Feb;8(2):196-215. doi: 10.1158/2159-8290.CD-17-0833. Epub 2017 Nov 3.

4.

Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.

Hanna GJ, Liu H, Jones RE, Bacay AF, Lizotte PH, Ivanova EV, Bittinger MA, Cavanaugh ME, Rode AJ, Schoenfeld JD, Chau NG, Haddad RI, Lorch JH, Wong KK, Uppaluri R, Hammerman PS.

Oral Oncol. 2017 Apr;67:61-69. doi: 10.1016/j.oraloncology.2017.02.005. Epub 2017 Feb 14.

PMID:
28351582
5.

Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors.

Awad MM, Jones RE, Liu H, Lizotte PH, Ivanova EV, Kulkarni M, Herter-Sprie GS, Liao X, Santos AA, Bittinger MA, Keogh L, Koyama S, Almonte C, English JM, Barlow J, Richards WG, Barbie DA, Bass AJ, Rodig SJ, Hodi FS, Wucherpfennig KW, Jänne PA, Sholl LM, Hammerman PS, Wong KK, Bueno R.

Cancer Immunol Res. 2016 Dec;4(12):1038-1048. Epub 2016 Nov 14.

6.

Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes.

Lizotte PH, Ivanova EV, Awad MM, Jones RE, Keogh L, Liu H, Dries R, Almonte C, Herter-Sprie GS, Santos A, Feeney NB, Paweletz CP, Kulkarni MM, Bass AJ, Rustgi AK, Yuan GC, Kufe DW, Jänne PA, Hammerman PS, Sholl LM, Hodi FS, Richards WG, Bueno R, English JM, Bittinger MA, Wong KK.

JCI Insight. 2016 Sep 8;1(14):e89014. doi: 10.1172/jci.insight.89014.

7.

Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironment.

Lizotte PH, Jones RE, Keogh L, Ivanova E, Liu H, Awad MM, Hammerman PS, Gill RR, Richards WG, Barbie DA, Bass AJ, Bueno R, English JM, Bittinger M, Wong KK.

Sci Rep. 2016 Aug 19;6:31745. doi: 10.1038/srep31745.

8.

TMEM203 Is a Novel Regulator of Intracellular Calcium Homeostasis and Is Required for Spermatogenesis.

Shambharkar PB, Bittinger M, Latario B, Xiong Z, Bandyopadhyay S, Davis V, Lin V, Yang Y, Valdez R, Labow MA.

PLoS One. 2015 May 21;10(5):e0127480. doi: 10.1371/journal.pone.0127480. eCollection 2015.

9.

Use of the stag-beetle knife for peroral endoscopic myotomy for achalasia: a novel method for myotomy.

Bittinger M, Messmann H.

Gastrointest Endosc. 2015 Aug;82(2):401-2. doi: 10.1016/j.gie.2015.03.1906. Epub 2015 Apr 25. No abstract available.

PMID:
25922252
10.

[Chronic critically ill patients from a gastroenterological perspective].

Bittinger M, Messmann H.

Med Klin Intensivmed Notfmed. 2013 May;108(4):285-9. doi: 10.1007/s00063-012-0195-x. Epub 2013 Feb 21. Review. German.

PMID:
23423578
11.

[Acute pancreatitis].

Bittinger M, Messmann H.

Med Klin Intensivmed Notfmed. 2011 Nov;106(3):221-30; quiz 231. doi: 10.1007/s00063-011-0019-4. Review. German. No abstract available.

PMID:
22068758
12.

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.

Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, Lai A, Cloughesy TF, Kornblum HI, Wu H, Fantin VR, Liau LM.

J Neurooncol. 2012 Mar;107(1):197-205. doi: 10.1007/s11060-011-0737-8. Epub 2011 Oct 21.

13.

Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: an international prospective multicentre registry.

Costamagna G, Tringali A, Spicak J, Mutignani M, Shaw J, Roy A, Johnsson E, De Moura EG, Cheng S, Ponchon T, Bittinger M, Messmann H, Neuhaus H, Schumacher B, Laugier R, Saarnio J, Ariqueta FI.

Dig Liver Dis. 2012 Jan;44(1):37-43. doi: 10.1016/j.dld.2011.08.012. Epub 2011 Sep 19.

PMID:
21937292
14.

Cancer-associated IDH mutations: biomarker and therapeutic opportunities.

Yen KE, Bittinger MA, Su SM, Fantin VR.

Oncogene. 2010 Dec 9;29(49):6409-17. doi: 10.1038/onc.2010.444. Epub 2010 Oct 25. Review.

PMID:
20972461
15.

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM.

Nature. 2010 Jun 17;465(7300):966. doi: 10.1038/nature09132. No abstract available.

16.

Gastric ischemia following endoscopic submucosal dissection of early gastric cancer.

Probst A, Maerkl B, Bittinger M, Messmann H.

Gastric Cancer. 2010 Mar;13(1):58-61. doi: 10.1007/s10120-009-0539-2. Epub 2010 Apr 7.

PMID:
20373077
17.

[Leptospirosis (Weil's disease) in Augsburg].

Walter B, Wein B, Bittinger M, Messmann H.

Dtsch Med Wochenschr. 2010 Apr;135(14):675-8. doi: 10.1055/s-0030-1251916. Epub 2010 Mar 31. German.

PMID:
20358494
18.

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.

Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG, Sasaki M, Jin S, Schenkein DP, Su SM, Dang L, Fantin VR, Mak TW.

J Exp Med. 2010 Feb 15;207(2):339-44. doi: 10.1084/jem.20092506. Epub 2010 Feb 8.

19.

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM.

Nature. 2009 Dec 10;462(7274):739-44. doi: 10.1038/nature08617.

20.

A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia.

Conio M, Repici A, Battaglia G, De Pretis G, Ghezzo L, Bittinger M, Messmann H, Demarquay JF, Blanchi S, Togni M, Conigliaro R, Filiberti R.

Am J Gastroenterol. 2007 Dec;102(12):2667-77.

PMID:
18042102
21.

Self-expanding metal stents as nonsurgical palliative therapy for malignant colonic obstruction: time to change the standard of care?

Bittinger M, Messmann H.

Gastrointest Endosc. 2007 Nov;66(5):928-30. No abstract available.

PMID:
17963879
22.

Can an endocytoscope system (ECS) predict histology in neoplastic lesions?

Eberl T, Jechart G, Probst A, Golczyk M, Bittinger M, Scheubel R, Arnholdt H, Knuechel R, Messmann H.

Endoscopy. 2007 Jun;39(6):497-501.

PMID:
17554643
23.

Gastroesophageal reflux disease and Barrett's esophagus.

Bittinger M, Messmann H.

Endoscopy. 2007 Feb;39(2):118-23. Review. No abstract available.

PMID:
17327970
24.

Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study.

Conigliaro R, Battaglia G, Repici A, De Pretis G, Ghezzo L, Bittinger M, Messmann H, Demarquay JF, Togni M, Blanchi S, Filiberti R, Conio M.

Eur J Gastroenterol Hepatol. 2007 Mar;19(3):195-203.

PMID:
17301645
25.

Is nonsurgical management safe and effective for patients with microperforation caused by EMR?

Bittinger M, Messmann H.

Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):134-5. Epub 2007 Feb 6. No abstract available.

PMID:
17290237
26.

[Aortoduodenal fistula as a cause of gastrointestinal bleeding--difficulties in endoscopic diagnosis].

Probst A, Bittinger M, Eberl T, Jakob R, Zinkl K, Heiss A, Eser R, Häckel T, Messmann H.

Z Gastroenterol. 2006 Mar;44(3):239-44. German.

PMID:
16514569
27.

[Endoscopic reflux therapy by Endocinch].

Bittinger M, Messmann H.

Z Gastroenterol. 2003 Feb;41(2):204-6. German. No abstract available.

PMID:
16308927
28.

Are endoscopic antireflux procedures useful?

Bittinger M, Messmann H.

Nat Clin Pract Gastroenterol Hepatol. 2005 Jan;2(1):4-5. Review. No abstract available.

PMID:
16265076
29.

Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins.

Bittinger MA, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X, Chen CH, Song C, Garza D, Labow M.

Curr Biol. 2004 Dec 14;14(23):2156-61.

30.

[New endoscopic therapies for gastroesophageal reflux disease].

Bittinger M, Messmann H.

Z Gastroenterol. 2003 Sep;41(9):921-8. Review. German.

PMID:
13130330
31.

Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor.

Bittinger MA, Nguyen LP, Bradfield CA.

Mol Pharmacol. 2003 Sep;64(3):550-6.

PMID:
12920190
32.

Autonomic nervous system evaluation: diagnosis of rectal and lower gut dysfunction.

Bittinger M, Wienbeck M.

Suppl Clin Neurophysiol. 2000;53:228-30. Review.

PMID:
12741002
33.

Pneumatic dilation in achalasia.

Bittinger M, Wienbeck M.

Can J Gastroenterol. 2001 Mar;15(3):195-9. Review.

PMID:
11264573
34.

[Diagnosis and therapy of chronic constipation].

Bittinger M, Schmidbaur W, Wienbeck M.

Praxis (Bern 1994). 2000 Oct 12;89(41):1651-5. Review. German.

PMID:
11081367
35.

Rhizobium etli CE3 carries vir gene homologs on a self-transmissible plasmid.

Bittinger MA, Gross JA, Widom J, Clardy J, Handelsman J.

Mol Plant Microbe Interact. 2000 Sep;13(9):1019-21.

36.

Identification of genes in the RosR regulon of Rhizobium etli.

Bittinger MA, Handelsman J.

J Bacteriol. 2000 Mar;182(6):1706-13.

37.

Autonomic dysfunction and the gastrointestinal tract.

Bittinger M, Barnert J, Wienbeck M.

Clin Auton Res. 1999 Apr;9(2):75-81. Review.

PMID:
10225611
38.

[Diagnosis and therapy of fecal incontinence].

Bittinger M, Wienbeck M, Barnert J.

Praxis (Bern 1994). 1998 Nov 26;87(48):1637-42. Review. German.

PMID:
9881035
39.

Postprandial gastric relaxation in achalasia.

Bittinger M, Barnert J, Eberl T, Wienbeck M.

Eur J Gastroenterol Hepatol. 1998 Sep;10(9):741-4.

PMID:
9831267
40.

["Alternative" therapy methods in functional disorders of the gastrointestinal system].

Bittinger M, Barnert J, Wienbeck M.

Z Gastroenterol. 1998 Jun;36(6):519-24. Review. German.

PMID:
9675838
41.

rosR, a determinant of nodulation competitiveness in Rhizobium etli.

Bittinger MA, Milner JL, Saville BJ, Handelsman J.

Mol Plant Microbe Interact. 1997 Mar;10(2):180-6.

42.

24-hour oesophageal motility in gastro-oesophageal reflux disease (GORD): increased occurrence of simultaneous contractions.

Bittinger M, Barnert J, Demharter R, Wienbeck M.

Eur J Gastroenterol Hepatol. 1996 Mar;8(3):201-4.

PMID:
8724017
43.

[Conservative therapy of fecal incontinence].

Bittinger M, Barnert J, Moll A, Majewicz A, Wienbeck M.

Zentralbl Chir. 1996;121(8):665-8. Review. German.

PMID:
8967213
45.

[Normal and abnormal gastrointestinal motility].

Bittinger M, Barnert J, Wienbeck M.

Fortschr Med. 1993 Feb 20;111(5):65-70. Review. German.

PMID:
8449472

Supplemental Content

Loading ...
Support Center